Search Ontology:
ChEBI
selinexor
- Term ID
- CHEBI:229764
- Synonyms
-
- (2Z)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1- yl}-N'-(pyrazin-2-yl)prop-2-enehydrazide
- (2Z)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}-N'-(pyrazin-2-yl)prop-2-enehydrazide
- KPT 330
- KPT-330
- selinexor
- selinexorum
- Xpovio
- Definition
- A member of the class of triazoles that is 1H-1,2,4-triazole substituted by (1Z)-3-oxo-3-[2-(pyrazin-2-yl)hydrazinyl]prop-1-en-1-yl and 3,5-bis(trifluoromethyl)phenyl groups at positions 1 and 3, respectively. It is a prescription medicine approved for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
- References
-
- drugbank:DB11942
- hmdb:HMDB0258217
- kegg.drug:D11222
- pubmed:23373539
- pubmed:27893412
- pubmed:28314790
- pubmed:28810913
- pubmed:28852098
- pubmed:29707241
- pubmed:30064906
- pubmed:30115935
- pubmed:30996012
- pubmed:32598257
- pubmed:33403670
- pubmed:33507295
- pubmed:33601919
- pubmed:34488662
- pubmed:34669417
- pubmed:34741230
- pubmed:35355406
- pubmed:35477814
- pubmed:35667526
- pubmed:35941226
- pubmed:36180918
- pubmed:36200270
- pubmed:36622814
- pubmed:36731340
- pubmed:36827679
- pubmed:36847599
- pubmed:37016732
- pubmed:37046649
- pubmed:37047788
- pubmed:37079389
- pubmed:37094850
- pubmed:37126200
- pubmed:37175668
- pubmed:37184196
- pubmed:37191210
- pubmed:37346402
- pubmed:37595020
- pubmed:37715291
- pubmed:37760508
- pubmed:37945593
- pubmed:38105606
- pubmed:38186637
- pubmed:38454813
- wikipedia.en:Selinexor
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from selinexor
Phenotype where environments contain selinexor
Phenotype modified by environments containing selinexor
Phenotype affecting selinexor
Human Disease Model